NCT00602589View on ClinicalTrials.gov

A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

November 30, 2002

Conditions

Healthy

Interventions

DRUG

Levofloxacin oral suspension; Levofloxacin oral solution; and Levofloxacin marketed tablet formulations

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00602589 - A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects | Biotech Hunter | Biotech Hunter